Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: A prospective phase I/II trial

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 5, 2005, Pages 1423-1431

  Hehr, Thomas ^a   Classen, Johannes ^a   Belka, Claus ^a   Welz, Stefan ^a   Schäfer, Juergen ^a   Koitschev, Assen ^a   Bamberg, Michael ^a   Budach, Wilfried ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alternating chemoradiation; Cisplatin; Docetaxel; Recurrent head and neck cancer; Reirradiation

Indexed keywords

CELLS; CHEMOTHERAPY; DOSIMETERS; PATIENT MONITORING; TOXICITY; TUMORS;

BRACHYTHERAPY; CHEMORADIATION; CHEMOREIRRADIATION; HEMATOLOGIC TOXICITY;

RADIOTHERAPY;

CISPLATIN; DOCETAXEL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; LEUKOPENIA; LONG TERM CARE; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RATING SCALE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

EID: 16344371166     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.08.020     Document Type: Article

References (65)

1. V.A. Marcial, T.F. Pajak, S. Kramer Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer Semin Oncol 15 1988 39 60
2. J. Ridge Squamous cancer of the head and neck Surgical treatment of local and regional recurrence Semin Oncol 20 1993 419 429
3. W.K. Hong, R.H. Bromer, D.A. Amato Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment Cancer 45 1985 1242 1245
4. C. Jacobs, G. Lyman, E. Velez-Garcia A phase III randomized study comparing cisplatinum and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 1992 267-263
5. A.A. Forastierre, D. Neuberg, S.G. Taylor Phase II evaluation of Taxol in advanced head and neck cancer An Eastern Cooperative Oncology Group trial J Natl Cancer Inst Monogr 15 1993 181 184
6. J.A. Kish, A. Weaver, J. Jacobs Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck Cancer 53 1984 1819 1824
7. W.K. Hong, R. Bromer Chemotherapy in head and neck cancer N Engl J Med 308 1983 75 79
8. K.R. Stevens, A. Britsch, W.T. Moss High-dose re-irradiation of head and neck cancer with curative intent Int J Radiat Oncol Biol Phys 29 1994 687 698
9. B. Emami, J.E. Marks, C.A. Perez Interstitial thermoradiotherapy in the treatment of recurrent/residual malignant tumors Am J Clin Oncol 7 1984 699 704
10. B. Emami, J.E. Marks Re-treatment of recurrent carcinoma of the head and neck by afterloading interstitial 192IR implant Laryngoscope 93 1983 1345 1347
11. J.J. Mazeron, D. Langlois, D. Glaubiger Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants 5-Year results of 70 cases Int J Radiat Oncol Biol Phys 13 1987 957 962
12. A.A. Puthawala, A.M.N. Syed Interstitial re-irradiation for recurrent and/or persistent head and neck cancers Int J Radiat Oncol Biol Phys 13 1987 1113 1114
13. R. De Crevoisier, J. Bourhis, C. Domenge Full-dose re-irradiation of head and neck carcinoma Experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 1998 3556 3562
14. C.C. Wang, J. McIntyre Re-irradiation of laryngeal carcinoma Techniques and results Int J Radiat Oncol Biol Phys 26 1993 783 785
15. D. Langlois, F. Eschwege, A. Kramer Re-irradiation of head and neck cancers Radiother Oncol 3 1985 27 33
16. J. Pomp, P.C. Levendag, W.L.J. van Putten Re-irradiation of recurrent tumors in the head and neck Am J Clin Oncol 11 1988 543 549
17. C.C. Wang Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results Int J Radiat Oncol Biol Phys 13 1987 953 956
18. R. Million, N. Cassisi, J. Clark Cancer of the head and neck V.T. DeVita Jr S. Hellmann S.A. Rosenberg Cancer Principles and practice of oncology 1989 Lippincott Philadelphia 488 590
19. M.S. Kies, D.J. Haraf, F. Rosen Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer J Clin Oncol 19 2001 1961 1969
20. L.A. Dawson, L.L. Myers, C.R. Bradford Conformal re-irradiation of recurrent and new primary head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 377 385
21. B. Emami, M. Bignardi, V.R. Devineni Re-irradiation of head and neck cancers Laryngoscope 97 1987 85 88
22. E.E. Vokes, D.J. Haral, R. Mick Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer J Clin Oncol 12 1994 2351 2359
23. W.F. Hartsell, C.R. Thomas, A.K. Murthy Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (ESTP-C385) Am J Clin Oncol (CCT) 17 1994 338 343
24. S.A. Spencer, J. Harris, R.H. Wheeler RTOG 96-10 Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 2001 1299 1304
25. S.J. Chmura, E.E. Vokes, M. Garofalo Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 57 Suppl. 2 2003 409 410
26. D. Haraf, R. Weichselbaum, E. Vokes Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer A potentially curable disease Ann Oncol 7 1996 913 918
27. D. Haraf, T. Chung, K. Stenson High dose reirradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (HNC) Results in 48 patients [Abstract] Proc Am Soc Clin Oncol 19 2000 413a
28. J. Crown, M. O'Leary The taxanes An update Lancet 355 2000 1176 1178
29. K. Gelmon The taxoids Paclitaxel and docetaxel Lancet 344 1994 1267 1272
30. B.J.M. Braakhuis, A. Kegel, M.J.P. Welters The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts Cancer Lett 81 1994 151 154
31. G. Catimel, J. Verweij, V. Mattijssen Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck: EORTC Early Clinical Trials Group Ann Oncol 5 1994 533 537
32. A.I. Dreyfuss, J.R. Clark, C.M. Norris Docetaxel An active drug for squamous cell carcinoma of the head and neck J Clin Oncol 14 1996 1672 1678
33. R.A. Britten, S. Perdue, J. Opoku Paclitaxel is preferentially cytotoxic to human cervical tumor cells with low Raf-1 kinase activity Implications for paclitaxel-based chemoradiation regimens Radiother Oncol 48 1998 329 334
34. J. Kao, M.C. Garofalo, M.T. Milano Reirradiation of recurrent and second primary head and neck malignancies A comprehensive review Cancer Treat Rev 29 2003 21 30
35. M. Suzuki, Y. Nishimura, K. Nakamatsu Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer Jpn J Clin Oncol 33 2003 297 301
36. K. Hesse, B. Heinrich, F. Zimmermann Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors Strahlenther Onkol 176 2000 67 72
37. K.K. Ang, G.L. Jiang, Y. Feng, L.C. Stephens, S.L. Tucker, R.E. Price Extent and kinetics of recovery of occult spinal cord injury Int J Radiat Oncol Biol Phys 50 2001 1013 1020
38. J. Lawless Statistical models and methods for lifetime data 1982 John Wiley & Sons New York
39. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
40. P. Therasse, S.G. Arbuck, E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
41. J.A. Forrest, N.D. Finlayson, D.J. Shearman Endoscopy in gastrointestinal bleeding Lancet 17 1974 394 397
42. B. Weppelmann, R.H. Wheeler, G.E. Peters Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation Int J Radiat Oncol Biol Phys 22 1992 1051 1056
43. F. Sanchiz, A. Milla, J. Torner Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer Int J Radiat Oncol Biol Phys 19 1990 1347 1350
44. T.C. Lo, A.L. Wiley Jr, F.J. Ansfield Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx A randomized study Am J Roentgenol 126 1976 229 235
45. G.P. Browman, C. Cripps, D.I. Hodson Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer J Clin Oncol 12 1994 2648 2653
46. F. Denis, P. Garaud, E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
47. D.J. Adelstein, Y. Li, G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
48. B. Jeremic, Y. Shibamoto, B. Stanisavljevic Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck A prospective randomized trial Radiother Oncol 43 1997 29 37
49. P. Olmi, S. Crispino, C. Fallai Locoregionally advanced carcinoma of the oropharynx Conventional radiotherapy vs accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 2003 78 92
50. J.T. Parsons, F.J. Bova, R.R. Million A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 6 1980 1645 1652
51. B. Maciejewski, H.R. Withers, J.M. Taylor Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx Tumor dose-response and repopulation Int J Radiat Oncol Biol Phys 16 1989 831 843
52. J.A. Damsker, C.J. Langer, J. Cheng Safety and outcome of concurrent hyperfractionated split course radiotherapy with daily cisplatin and paclitaxel in patients with recurrent, unresectable, previously irradiated head and neck cancer [Abstract] Proc Am Soc Clin Oncol 22 2003 499a
53. M. Merlano, M. Benasso, R. Corvo Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583 589
54. Bissery MC, Nohynek G, Sanderink GJ, et al. Docetaxel (Taxotere): A review of preclinical and clinical experience. Anti-Cancer Drugs 1995;6:339-355;363-368.
55. S. Ebihara, H. Fujii, Y. Sasaki A late phase II study of docetaxel (Taxotere) in patients with head and neck cancer (HNC) [Abstract] Proc Am Soc Clin Oncol 16 1997 399a
56. D.M. Shin, B.S. Glisson, B.S. Khuri Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma J Clin Oncol 16 1998 1325 1330
57. U. Schäfer, O. Micke, P. Schüller Recurrent head and neck cancer Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy--results of a prospective study Radiology 216 2000 371 376
58. A.T. Van Oosterom, D. Schrilvers Docetaxel, a review of preclinical and clinical experience: Part II: Clinical experience Anti-Cancer Drugs 6 1995 356 368
59. P. Schöffski, G. Catimel, A.S.T. Planting Docetaxel and cisplatin An active regimen in patients with locally advanced, recurrent or metastatic squamous-cell carcinoma of the head and neck Ann Oncol 10 1999 119 122
60. J. Janinis, M. Papadakou, E. Xidakis Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer A phase II feasibility study Am J Clin Oncol 23 2000 128 131
61. B. Murphy, Y. Li, D. Cella Phase III study comparing cisplatin (C) and 5-fluorouracil (F) versus cisplatin and paclitaxel (T) in metastatic/recurrent head and neck cancer (MHNC) [Abstract] Proc Am Soc Clin Oncol 20 2001 413a
62. R. De Crevoisier, C. Domenge, P. Wibault Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma Cancer 91 2001 2071 2076
63. C. Nieder, L. Milas, K.K. Ang Tissue tolerance to reirradiation Semin Radiat Oncol 10 2000 200 209
64. A.M. Julia, J.M. Bachaud, P. Canal Radiosensitivity of jejunal mucosa after whole abdomen irradiation and CDDP pretreatment Int J Radiat Oncol Biol Phys 20 1991 343 345
65. M. Henke, R. Laszig, C. Rube Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy Randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260